Saw Palmetto and the Prostate: A Mixed Record
Quick Answer: Does Saw Palmetto Work?
For urinary symptoms, probably not. The CAMUS trial — 369 men, randomised, placebo-controlled, running up to triple the usual dose for 72 weeks — found no meaningful improvement over placebo. Earlier, smaller studies were positive, and the most likely explanation is that they were less rigorous rather than that the larger trial missed something. For male vitality specifically, there is essentially no direct evidence; saw palmetto is a prostate ingredient that ended up in vitality blends by convention.
- Best evidence: the CAMUS trial, and it was negative.
- Typical dose: 320 mg daily of a lipidosterolic extract.
- Practical caution: it can lower a PSA reading.
What it is, and why it became popular
Serenoa repens is a fan palm native to the south-eastern United States. Its berries have been used for urinary complaints since long before anyone measured prostate volume, and the modern supplement is a lipidosterolic extract standardised to roughly 85–95% fatty acids and sterols.
The proposed mechanism is inhibition of 5-alpha reductase, the enzyme converting testosterone into dihydrotestosterone — the same target as the prescription drug finasteride. That is a coherent story, and it is the reason saw palmetto was taken seriously enough to be tested properly.
The trial that settled it
The Complementary and Alternative Medicine for Urological Symptoms study, published in JAMA in 2011, is the one that matters. It randomised 369 men with lower urinary tract symptoms to saw palmetto or placebo, and escalated the dose from 320 mg to 640 mg and then 960 mg per day over 72 weeks.
The result was flat. There was no significant difference in symptom scores at any dose, including triple the amount sold in most supplements. A Cochrane review reached the same conclusion across the wider literature: the more rigorous the study, the smaller the effect.
| Outcome | Evidence quality | Honest summary |
|---|---|---|
| Urinary symptoms (BPH) | Good — and negative | Large randomised trial found no benefit over placebo |
| Prostate volume | Weak | No consistent effect demonstrated |
| Male vitality / libido | Insufficient | Not what it was studied for |
| Hair loss | Very limited | A few small studies, not comparable to finasteride |
| Tolerability | Good | Consistently well tolerated across trials |
So why is it in almost every blend?
Because it is expected. Saw palmetto is the botanical men recognise when they think about prostate health, it is inexpensive, and its absence from an ingredient list is more likely to cost a sale than its weak evidence is. That is a commercial reason, not a scientific one, and it is worth naming plainly. The Cochrane review of thirty-two randomised trials reached the same conclusion the CAMUS trial did, finding no improvement in urinary symptom scores over placebo (Tacklind et al., Cochrane Database of Systematic Reviews, 2012), which is also why the comparison with the other common prostate botanical, set out in our piece on saw palmetto versus beta-sitosterol for prostate support, ends up favouring neither by much.
Its presence in a formula is not a mark against that formula. It is simply not a reason to choose one — and if a product's case rests mainly on containing saw palmetto, that case is weaker than it sounds.
The PSA problem
This is the practical point worth carrying away. Saw palmetto can lower measured prostate-specific antigen. If you are being monitored, a suppressed reading could mask a change your doctor would otherwise investigate.
It is not a reason to avoid it. It is a reason to mention it at your next appointment, in the same way you would mention any other supplement. A review of dietary factors that shift PSA readings sets out how easily a supplement can move that number (Dietary factors and supplements influencing prostate-specific antigen concentrations, Nutrients, 2020), and the wider category is covered in our survey of what the evidence shows for prostate supplements.
What this means in practice
If you are taking a blended formula that happens to contain saw palmetto, there is no cause for concern — it is safe and well tolerated. If you are buying a supplement specifically to improve urinary symptoms, the evidence does not support that choice, and a urologist is a better use of the money. And whichever applies, tell your doctor, because of the PSA effect. If you are weighing a blended product rather than a single herb, the useful skill is reading the panel: our walkthrough of the Horsewood ingredients label shows how to check a stated amount against the amount a trial actually used, and our guide to comparing men's libido supplements applies the same test across a shelf. For a plain-language summary of where the science sits, the National Center for Complementary and Integrative Health page on saw palmetto reaches the same verdict.
Frequently asked questions
Does saw palmetto shrink the prostate?
The evidence does not support that. The CAMUS trial, the largest and best-designed study, found no improvement in urinary symptom scores over placebo even at triple the standard dose. Earlier smaller studies were more positive, and the discrepancy is best explained by their methodological limits.
Does saw palmetto affect a PSA test?
It can. Saw palmetto may lower measured PSA, which risks masking a reading your doctor would otherwise act on. Anyone being monitored for prostate health should tell their doctor they are taking it.
Why is saw palmetto in so many supplements?
Familiarity and category convention rather than strength of evidence. It is the best-known prostate botanical, inexpensive, and customers expect to see it, so it appears in blends whose purpose has little to do with urinary symptoms.
Is saw palmetto safe?
It is generally well tolerated. Reported side effects are mild and mostly digestive. The two practical cautions are its effect on PSA readings and a theoretical interaction with blood-thinning medication.
How Horsewood uses saw palmetto
It is one of seven botanicals in the formula. See where the evidence is stronger — and where it is not.
Read the Full ReviewReferences
- Barry MJ, Meleth S, Lee JY, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: the CAMUS randomized trial. JAMA, 2011. PubMed 21954478
- Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews, 2012. PubMed 23235581
- Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. New England Journal of Medicine, 2006. PubMed 16467543
- Habib FK, Wyllie MG. Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract. Prostate Cancer and Prostatic Diseases, 2004. PubMed 15289814
- Mahmood H, Cormie P, Galvão DA, et al. Dietary factors and supplements influencing prostate-specific antigen (PSA) concentrations in men with prostate cancer and increased cancer risk. Nutrients, 2020. PubMed 33003518
About Horsewood, the product this site covers
Horsewood is a two-a-day gelatin capsule sold for male vitality, carrying seven openly dosed ingredients — tongkat ali, horny goat weed, saw palmetto, wild yam, sarsaparilla, nettle leaf and boron amino acid chelate — at 60 capsules a bottle. Our Horsewood ingredients, price and official website guide reads the Supplement Facts panel line by line and compares each amount with the amount its supporting trial actually used. The rest of this research library is indexed on the Horsaewood evidence blog.
Affiliate disclosure (FTC 16 CFR Part 255). Horsaewood Media is an independent publisher, not the manufacturer or seller. Links marked “Get Offer” are affiliate links: if you buy through one we may earn a commission at no extra cost to you, and that commission has not changed what this article says about the evidence. FDA statement. These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. This article is information, not medical advice — see our medical disclaimer.